BioSpace News Archive

BIOCORP, a French company specialized in the design, development and manufacturing of innovative medical devices, and Roche Diabetes Care France, a reference company in the support of patients with diabetes, announce the launch in France of Mallya, a medical device available in pharmacies.

First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the Medicines Evaluation Unit in Manchester, UK

Harbour BioMed, a global clinical-stage biopharmaceutical company, presents its newly discovered fully human anti-B7H7 monoclonal antibody at the American Association for Cancer Research Annual Meeting.

Eli Lilly and Company announced that Diogo Rau will join the company on May 17, 2021 as senior vice-president and chief information and digital officer.

Soligenix, Inc. announced today planned conference presentations scheduled through April and May.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro’s Chairman, CEO and President, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 2:00 pm Eastern Time / 11:00 am Pacific Time.

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team will present at the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference on Tuesday, April 20, 2021

- Company to further expand its DECODE™ discovery platform, accelerate multiple oncology clinical programs, and advance discovery programs in oncology, autoimmune disorders, infectious disease, and other serious diseases

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that Michele Fournier has joined the company as Chief People Officer. Bringing more than thirty years of global human resources experience in corporate and consulting roles

The following statement is attributed to Dr. Peter Marks , director of the FDA’s Center for Biologics Evaluation and Research and Dr. Anne Schuchat , Principal Deputy Director of the CDC As of April 12 , more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S.